Live Breaking News & Updates on Gene Therapy Technologies
Stay updated with breaking news from Gene therapy technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MALVERN, Pa., June 30, 2023 Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today. ....
Global Cell & Gene Therapy Technologies & Supplies Industry Forecast to 2025: Market Demand, Competitive Landscape Analysis, and Market Shares of 13 Vendors in 21 Techniques prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Global Cell & Gene Therapy Technologies & Supplies Industry Forecast to 2025: Market Demand, Competitive Landscape Analysis, and Market Shares of 13 Vendors in 21 Techniques prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
2 Billion Dollar Tools Market for Cell and Gene Therapy, Says Report Share Article Strategic Directions International (SDi) shares insights from its recent report on the market for cell and gene therapy technologies. ARLINGTON, Va. (PRWEB) April 27, 2021 The market for selected technologies and supplies commonly used in cell and gene therapy (CGT) research, development, clinical trial, and product manufacturing exceeded $2.1 billion in 2020. This was the finding made in Cell & Gene Therapy Technologies and Supplies, a market research report by Strategic Directions International, part of Science and Medicine Group. SDi s report breaks the market into specific categories with defined markets. The market is led by cell expansion products, driven by costly GMP-grade consumables that are necessary for the culture of cells that are destined for infusion into humans. Currently, clinical trials ....